These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35277401)

  • 21. The association between chronic kidney disease and tuberculosis; a comparative cohort study in England.
    Ruzangi J; Iwagami M; Smeeth L; Mangtani P; Nitsch D
    BMC Nephrol; 2020 Oct; 21(1):420. PubMed ID: 32998703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.
    Chang YT; Liu CC; Tsai LM; Li CY; Sung JM
    Medicine (Baltimore); 2014 Dec; 93(28):e261. PubMed ID: 25526451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria.
    Marcos G; Santabárbara J; Lopez-Anton R; De-la-Cámara C; Gracia-García P; Lobo E; Pírez G; Menchón JM; Palomo T; Stephan BC; Brayne C; Lobo A;
    Acta Psychiatr Scand; 2016 May; 133(5):378-85. PubMed ID: 26685927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
    Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
    Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.
    Drew DA; Weiner DE; Sarnak MJ
    Am J Kidney Dis; 2019 Dec; 74(6):782-790. PubMed ID: 31378643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactive effect of obesity and cognitive function decline on the risk of chronic kidney disease progression in patients with type 2 diabetes mellitus: a 9.1-year cohort study.
    Lu YC; Wang CP; Hung WC; Wu CC; Yu TH; Hsu CC; Wei CT; Chung FM; Lee YJ; Tang WH
    Int J Med Sci; 2022; 19(11):1660-1671. PubMed ID: 36237991
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognition in chronic kidney disease patients: Evaluation with the Beijing version of the Montreal Cognitive Assessment.
    An J; Sun W; Zhang W; Yu Z; Gao K; Zhao J; Sun S; An J; Ji A
    Appl Neuropsychol Adult; 2022; 29(4):520-526. PubMed ID: 32608267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between chronic kidney disease and incident diagnosis of dementia in England: a cohort study in Clinical Practice Research Datalink.
    Hiramatsu R; Iwagami M; Nitsch D
    BMJ Open; 2020 May; 10(5):e033811. PubMed ID: 32423927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
    Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
    Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.
    Chuang TF; Hung HC; Li SF; Lee MW; Pai JY; Hung CT
    BMC Nephrol; 2020 Jul; 21(1):292. PubMed ID: 32698782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between sex and incident chronic kidney disease in a prospective diabetic cohort.
    Yu MK; Katon W; Young BA
    Nephrology (Carlton); 2015 Jul; 20(7):451-8. PubMed ID: 25807970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence Rates of Dementia and Mild Cognitive Impairment Are Affected by the Diagnostic Parameter Changes for Neurocognitive Disorders in the DSM-5 in a Korean Population.
    Han JW; So Y; Kim TH; Lee DY; Ryu SH; Kim SY; Kim SG; Kim SK; Youn JC; Jhoo JH; Kim JL; Lee SB; Lee JJ; Kwak KP; Moon SW; Kim BJ; Bae JN; Woo JI; Jeong H; Park JH; Kim YJ; Kim KW
    Dement Geriatr Cogn Disord; 2017; 43(3-4):193-203. PubMed ID: 28237992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney function and cognitive decline in frail elderly: two faces of the same coin?
    Coppolino G; Bolignano D; Gareri P; Ruberto C; Andreucci M; Ruotolo G; Rocca M; Castagna A
    Int Urol Nephrol; 2018 Aug; 50(8):1505-1510. PubMed ID: 29868939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality in Mild Cognitive Impairment Diagnosed with DSM-5 Criteria and with Petersen's Criteria: A 17-Year Follow-Up in a Community Study.
    Santabárbara J; Gracia-García P; Pírez G; López-Antón R; De La Cámara C; Ventura T; Pérez-Sastre M; Lobo E; Saz P; Marcos G; Lobo A
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):977-986. PubMed ID: 27639289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan.
    Cheng KC; Chen YL; Lai SW; Mou CH; Tsai PY; Sung FC
    BMC Nephrol; 2012 Sep; 13():129. PubMed ID: 23020192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit.
    Barbay M; Taillia H; Nédélec-Ciceri C; Bompaire F; Bonnin C; Varvat J; Grangette F; Diouf M; Wiener E; Mas JL; Roussel M; Godefroy O;
    Stroke; 2018 May; 49(5):1141-1147. PubMed ID: 29643258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic kidney disease and cognitive impairment].
    Pépin M; Villain C
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Dec; 18(4):429-435. PubMed ID: 33155549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.
    Obrador GT; Villa AR; Olvera N; Gutiérrez V; Contreras D; Reyes R
    Arch Med Res; 2013 Nov; 44(8):650-4. PubMed ID: 24211753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.